Your browser doesn't support javascript.
loading
Phone contacts and treatment discontinuation predict survival cancer patients in a subsidized drug access program.
Ladner, Joël; Madi, Farah; Jayasundera, Roshel; Saba, Joseph; Audureau, Etienne.
Afiliación
  • Ladner J; Epidemiology & Health Promotion Department, Rouen University Hospital, Rouen, 76000, France.
  • Madi F; Axios International Consultants Ltd, Dubai, UAE.
  • Jayasundera R; Axios International, Paris, France.
  • Saba J; Axios International, Paris, France.
  • Audureau E; Paris Est Université, hôpital Henri Mondor Hôpital, Public Heath, Assistance Publique Hôpitaux de Paris, Créteil, 94000, France.
J Comp Eff Res ; 12(7): e220210, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37278943
Aim: Survival of patients with Hodgkin's lymphoma is lower in in low- and middle-income countries, but factors leading to these outcomes are poorly understood. The objective of this study was to identify predictive factors associated with overall survival among cancer patients undergoing therapy in seven low- and middle-income countries. Materials & methods: A multicenter cohort was conducted in Egypt, Malaysia, Mexico, Peru, Philippines, Thailand and Ukraine. Results. A total of 460 patients were included. Phone-based support during patient follow-up and number of patients seen by the physician provided a positive impact, while the number of adverse events remains a predictor of death and physician decision to stop treatment. Conclusion: Furthers research on the potential benefit of phone-based programs to support patients with chronic diseases treatments should be explored in less developed countries.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do sul / Asia / Mexico / Peru Idioma: En Revista: J Comp Eff Res Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do sul / Asia / Mexico / Peru Idioma: En Revista: J Comp Eff Res Año: 2023 Tipo del documento: Article País de afiliación: Francia